The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice
Open accessAbstract
Anti-N-methyl D-aspartate receptor (NMDAR) encephalitis is a severe neuropsychiatric disorder that associates with prominent memory and behavioural deficits. Patients' antibodies react with the N-terminal domain of the GluN1 (previously known as NR1) subunit of NMDAR causing in cultured neurons a selective and reversible internalization of cell-surface receptors. These effects and the frequent response to immunotherapy have suggested an antibody-mediated pathogenesis, but to date there is no animal model showing that patients' antibodies cause memory and behavioural deficits. To develop such a model, C57BL6/J mice underwent placement of ventricular catheters connected to osmotic pumps that delivered a continuous infusion of patients' or control cerebrospinal fluid (flow rate 0.25 µl/h, 14 days). During and after the infusion period standardized tests were applied, including tasks to assess memory (novel object recognition in open field and V-maze paradigms), anhedonic behaviours (sucrose preference test), depressive-like behaviours (tail suspension, forced swimming tests), anxiety (black and white, elevated plus maze tests), aggressiveness (resident-intruder test), and locomotor activity (horizontal and vertical). Animals sacrificed at Days 5, 13, 18, 26 and 46 were examined for brain-bound antibodies and the antibody effects on total and synaptic NMDAR clusters and protein concentration using confocal microscopy and immunoblot analysis. These experiments showed that animals infused with patients' cerebrospinal fluid, but not control cerebrospinal fluid, developed progressive memory deficits, and anhedonic and depressive-like behaviours, without affecting other behavioural or locomotor tasks. Memory deficits gradually worsened until Day 18 (4 days after the infusion stopped) and all symptoms resolved over the next week. Accompanying brain tissue studies showed progressive increase of brain-bound human antibodies, predominantly in the hippocampus (maximal on Days 13-18), that after acid extraction and characterization with GluN1-expressing human embryonic kidney cells were confirmed to be against the NMDAR. Confocal microscopy and immunoblot analysis of the hippocampus showed progressive decrease of the density of total and synaptic NMDAR clusters and total NMDAR protein concentration (maximal on Day 18), without affecting the post-synaptic density protein 95 (PSD95) and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors. These effects occurred in parallel with memory and other behavioural deficits and gradually improved after Day 18, with reversibility of symptoms accompanied by a decrease of brain-bound antibodies and restoration of NMDAR levels. Overall, these findings establish a link between memory and behavioural deficits and antibody-mediated reduction of NMDAR, provide the biological basis by which removal of antibodies and antibody-producing cells improve neurological function, and offer a model for testing experimental therapies in this and similar disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The tail suspension test: A new method for screening antidepressants in mice
Steru, L., Chermat, R., Thierry, B., & Simon, P. (1985) · Psychopharmacology · doi:10.1007/bf00428203 · Cited by 3,534
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
Dalmau, J., Gleichman, A. J., Hughes, E. G., Rossi, J. E., Peng, X., Lai, M., Dessain, S. K., Rosenfeld, M. R., Balice-Gordon, R., & Lynch, D. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70224-2 · Cited by 3,488
Self-citationBehavioral despair in mice: a primary screening test for antidepressants.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 3,320
Titulaer, M. J., McCracken, L., Gabilondo, I., Armangué, T., Glaser, C., Iizuka, T., Honig, L. S., Benseler, S. M., Kawachi, I., Martinez-Hernandez, E., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70310-1 · Cited by 3,165
Self-citationRecent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma
Dalmau, J., Tüzün, E., Wu, H., Masjuan, J., Rossi, J. E., Voloschin, A., Baehring, J. M., Shimazaki, H., Koide, R., King, D., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21050 · Cited by 2,492
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685
Regulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561 · cited 1×
“…NMDAR that cause psychosis) (Weiner et al., 2000; Gunduz-Bruce, 2009), and brain tissue studies of patients with schizophrenia or Alzheimer's disease in which several molecular pathways that modulate glutamate receptor trafficking or function are affected (Snyder et al., 2005; Hahn et al., 2006).”
Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines
Crawley, J., & Goodwin, F. K. (1980) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(80)90067-2 · Cited by 1,425
Jentsch, J. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00060-8 · Cited by 1,314
Gresa-Arribas, N., Titulaer, M. J., Torrents, A., Aguilar, E., McCracken, L., Leypoldt, F., Gleichman, A. J., Balice-Gordon, R., Rosenfeld, M. R., Lynch, D., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70282-5 · Cited by 1,306
Self-citationNMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders
Lau, C. G., & Zukin, R. S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2153 · Cited by 1,159 · cited 1×
“…learning, and behaviour depend on the proper function of the excitatory glutamate N-methyl D-aspartate receptor (NMDAR) and a-amino-3-hydroxy-5-methyl- 4-isoxazolepropionic acid receptor (AMPAR) and underlying mechanisms of synaptic plasticity (Lau and Zukin, 2007; Shepherd and Huganir, 2007).”
Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis
Hughes, E. G., Peng, X., Gleichman, A. J., Lai, M., Zhou, L., Tsou, R., Parsons, T. D., Lynch, D. R., Dalmau, J., & Balice-Gordon, R. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0167-10.2010 · Cited by 1,143
Self-citationMice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia
Mohn, A. R., Gainetdinov, R. R., Caron, M. G., & Koller, B. H. (1999) · Cell · doi:10.1016/s0092-8674(00)81972-8 · Cited by 1,075
Irani, S. R., Bera, K., Waters, P., Zuliani, L., Maxwell, S., Zandi, M. S., Friese, M. A., Galea, I., Kullmann, D. M., Beeson, D., et al. (2010) · Brain · doi:10.1093/brain/awq113 · Cited by 1,035 · cited 2×
“hypofunction, including memory loss and neuropsychiatric alterations ranging from psychosis to coma (Dalmau et al., 2008; Irani et al., 2010; Viaccoz et al., 2014).”
The cell biology of synaptic plasticity: AMPA receptor trafficking
Shepherd, J. D., & Huganir, R. L. (2007) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.23.090506.123516 · Cited by 978
Handley, S. L., & Mithani, S. (1984) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00504983 · Cited by 969
Lancaster, E., Lai, M., Peng, X., Hughes, E., Constantinescu, R., Raizer, J., Friedman, D., Skeen, M. B., Grisold, W., Kimura, A., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70324-2 · Cited by 928
Self-citationDefining criteria for autoimmune diseases (Witebsky's postulates revisited)
Rose, N. R., & Bona, C. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90244-f · Cited by 814
AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location
Lai, M., Hughes, E. G., Peng, X., Zhou, L., Gleichman, A. J., Shu, H., Matà, S., Kremens, D., Vitaliani, R., Geschwind, M. D., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21589 · Cited by 813
Self-citationPostnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes
Belforte, J. E., Zsiros, V., Sklar, E. R., Jiang, Z., Yu, G., Li, Y., Quinlan, E. M., & Nakazawa, K. (2010) · Nature Neuroscience · doi:10.1038/nn.2447 · Cited by 752
One-trial object recognition in rats and mice: Methodological and theoretical issues
Ennaceur, A. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.12.036 · Cited by 676
Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses
Filliol, D., Ghozland, S., Chluba, J., Martin, M., Matthes, H. W. D., Simonin, F., Befort, K., Gavériaux-Ruff, C., Dierich, A., LeMeur, M., et al. (2000) · Nature Genetics · doi:10.1038/76061 · Cited by 672
Self-citationWinters, B. D., Forwood, S. E., Cowell, R. A., Saksida, L. M., & Bussey, T. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1346-04.2004 · Cited by 586
Altered neuregulin 1–erbB4 signaling contributes to NMDA> receptor hypofunction in schizophrenia
Hahn, C.-G., Wang, H.-Y., Cho, D.-S., Talbot, K., Gur, R. E., Berrettini, W. H., Bakshi, K., Kamins, J., Borgmann-Winter, K. E., Siegel, S. J., et al. (2006) · Nature Medicine · doi:10.1038/nm1418 · Cited by 563
Anti-NMDA receptor encephalitis in Japan: Long-term outcome without tumor removal
Iizuka, T., Sakai, F., Ide, T., Monzen, T., Yoshii, S., Iigaya, M., Suzuki, K., Lynch, D. R., Suzuki, N., Hata, T., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000278388.90370.c3 · Cited by 517
Self-citationPain responses, anxiety and aggression in mice deficient in pre-proenkephalin
König, M., Zimmer, A. M., Steiner, H., Holmes, P. V., Crawley, J. N., Brownstein, M. J., & Zimmer, A. (1996) · Nature · doi:10.1038/383535a0 · Cited by 484
Kayser, M. S., Titulaer, M. J., Gresa-Arribas, N., & Dalmau, J. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.3216 · Cited by 419
Self-citationCannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling
Puighermanal, E., Marsicano, G., Busquets-Garcia, A., Lutz, B., Maldonado, R., & Ozaita, A. (2009) · Nature Neuroscience · doi:10.1038/nn.2369 · Cited by 385
Self-citationAnalysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis
Martinez-Hernandez, E., Horvath, J., Shiloh-Malawsky, Y., Sangha, N., Martinez-Lage, M., & Dalmau, J. (2011) · Neurology · doi:10.1212/wnl.0b013e318228c136 · Cited by 375
Self-citationAcute mechanisms underlying antibody effects in anti–N‐methyl‐D‐aspartate receptor encephalitis
Moscato, E. H., Peng, X., Jain, A., Parsons, T. D., Dalmau, J., & Balice‐Gordon, R. J. (2014) · Annals of Neurology · doi:10.1002/ana.24195 · Cited by 367
Self-citationDisrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis
Mikasova, L., De Rossi, P., Bouchet, D., Georges, F., Rogemond, V., Didelot, A., Meissirel, C., Honnorat, J., & Groc, L. (2012) · Brain · doi:10.1093/brain/aws092 · Cited by 341
Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes
Hinson, S. R., Romero, M. F., Popescu, B. F. G., Lucchinetti, C. F., Fryer, J. P., Wolburg, H., Fallier-Becker, P., Noell, S., & Lennon, V. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109980108 · Cited by 328
Gleichman, A. J., Spruce, L. A., Dalmau, J., Seeholzer, S. H., & Lynch, D. R. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0064-12.2012 · Cited by 290
Self-citationAltered excitatory-inhibitory balance in the NMDA-hypofunction model of schizophrenia
Kehrer, C. (2008) · Frontiers in Molecular Neuroscience · doi:10.3389/neuro.02.006.2008 · Cited by 287
Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis
Viaccoz, A., Desestret, V., Ducray, F., Picard, G., Cavillon, G., Rogemond, V., Antoine, J.-C., Delattre, J.-Y., & Honnorat, J. (2014) · Neurology · doi:10.1212/wnl.0000000000000126 · Cited by 239
Sommer, C., Weishaupt, A., Brinkhoff, J., Biko, L., Wessig, C., Gold, R., & Toyka, K. V. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66376-3 · Cited by 224
Ketamine abusers presenting to the Emergency Department: A case series
Weiner, A. L., Vieira, L., McKay, C. A., & Bayer, M. J. (2000) · The Journal of Emergency Medicine · doi:10.1016/s0736-4679(00)00162-1 · Cited by 216
Taglialatela, G., Hogan, D., Zhang, W.-R., & Dineley, K. T. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.12.034 · Cited by 211
BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice
Aso, E., Ozaita, A., Valdizán, E. M., Ledent, C., Pazos, Á., Maldonado, R., & Valverde, O. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05149.x · Cited by 189
Self-citationThe acute effects of NMDA antagonism: From the rodent to the human brain
Gunduz-Bruce, H. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.07.006 · Cited by 182
Banovic, D., Khorramshahi, O., Owald, D., Wichmann, C., Riedt, T., Fouquet, W., Tian, R., Sigrist, S. J., & Aberle, H. (2010) · Neuron · doi:10.1016/j.neuron.2010.05.020 · Cited by 168
Berrendero, F., Mendizábal, V. E., Robledo, P., Galeote, L., Bilkei‐Gorzó, A., Zimmer, A., & Maldonado, R. J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3008-04.2005 · Cited by 142
Self-citationLi, Q., Clark, S., Lewis, D. V., & Wilson, W. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03070.2002 · Cited by 142
Manto, M. U., Dalmau, J. O., Didelot, A., Rogemond, V., & Honnorat, J. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-31 · Cited by 136
Self-citationStrekalova, T. V., Gorenkova, N., Shunk, E., Dolgov, O., & Bartsch, D. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200605000-00008 · Cited by 134
Zhang, Q., Tanaka, K., Sun, P., Nakata, M., Yamamoto, R., Sakimura, K., Matsui, M., & Kato, N. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.09.019 · Cited by 124
Mouri, A., Noda, Y., Noda, A., Nakamura, T., Tokura, T., Yura, Y., Nitta, A., Furukawa, H., & Nabeshima, T. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.032961 · Cited by 98
Caillé, S., Fernández‐Espejo, E., Rénéric, J.-P., Cador, M., Koob, G. F., & Stinus, L. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34977-8 · Cited by 87
Experimental Models of Neuromyelitis Optica
Bradl, M., & Lassmann, H. (2013) · Brain Pathology · doi:10.1111/bpa.12098 · Cited by 61
Operant model of frustrated expected reward in mice
Burokas, A., Cuesta, J., Martín‐García, E., & Maldonado, R. J. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00423.x · Cited by 56
Self-citationMouse strain variation in maximal electroshock seizure threshold
Ferraro, T. N., Golden, G. T., Smith, G. G., DeMuth, D., Buono, R. J., & Berrettini, W. H. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02565-9 · Cited by 55
Prolonged Follow-up and CSF Antibody Titers in a Patient With Anti-NMDA Receptor Encephalitis
Frechette, E. S., Zhou, L., Galetta, S. L., Chen, L., & Dalmau, J. O. (2011) · Neurology · doi:10.1212/wnl.0b013e31820c34de · Cited by 55
Self-citationEffects of chronic nicotine on food intake and anxiety-like behaviour in CB1 knockout mice
Bura, S. A., Burokas, A., Martín‐García, E., & Maldonado, R. J. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.02.003 · Cited by 48
Self-citationLlorente‐Berzal, A., Puighermanal, E., Burokas, A., Ozaita, A., Maldonado, R. J., Marco, E. M., & Viveros, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078386 · Cited by 47
Self-citationBura, S. A., Guegan, T., Zamanillo, D., Vela, J. M., & Maldonado, R. J. (2012) · European Journal of Pain · doi:10.1002/j.1532-2149.2012.00251.x · Cited by 44
Self-citationBura, S. A., Castañé, A., Ledent, C. A., Valverde, O., & Maldonado, R. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707152 · Cited by 27
Self-citation
Cited by
A clinical approach to diagnosis of autoimmune encephalitis
Graus, F., Titulaer, M. J., Balu, R., Benseler, S., Bien, C. G., Cellucci, T., Cortese, I., Dale, R. C., Gelfand, J. M., Geschwind, M., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00401-9 · Cited by 4,516
Self-citationAntibody-Mediated Encephalitis
Dalmau, J., & Graus, F. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1708712 · Cited by 1,329
Self-citationDalmau, J., Armangué, T., Planagumà, J., Radosevic, M., Mannara, F., Leypoldt, F., Geis, C., Lancaster, E., Titulaer, M. J., Rosenfeld, M. R., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30244-3 · Cited by 899
Self-citationStructure, Function, and Pharmacology of Glutamate Receptor Ion Channels
Hansen, K. B., Wollmuth, L. P., Bowie, D., Furukawa, H., Menniti, F. S., Sobolevsky, A. I., Swanson, G. T., Swanger, S. A., Greger, I. H., Nakagawa, T., et al. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000131 · Cited by 686
Dalmau, J., Geis, C., & Graus, F. (2017) · Physiological Reviews · doi:10.1152/physrev.00010.2016 · Cited by 628
Self-citation
Metadata
- Authors
- Planagumà, J., Leypoldt, F., Mannara, F., Gutiérrez-Cuesta, J., Martín-García, E., Aguilar, E., Titulaer, M. J., Petit-Pedrol, M., Jain, A., Balice-Gordon, R., Lakadamyali, M., Graus, F., Maldonado, R., & Dalmau, J.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-11-11
- Volume
- 138
- Issue
- 1
- Pages
- 94-109
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2075313898
- Cited by
- 489
- References
- 57
- FWCI
- 23.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.